chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Dose 1/Dose 2/The day after my pregnant wife received the vaccine, the doctors identified concerns with the pregnancy (related to blood flow in the umbilical cord); The day after my pregnant wife received the vaccine, the doctors identified concerns with the pregnancy (related to blood flow in the umbilical cord); This is a spontaneous report from a contactable consumer (husband). This consumer reported for reported information for both mother and fetus. This is the maternal report.   A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection, lot number and expiry date were not reported) via an unspecified route of administration on 23Aug2021 as dose 2, single; and via an unspecified route of administration on an unknown date as dose 1, single; for covid-19 immunisation. The patient's medical history and concomitant medications were not reported.  The patient had no other vaccine in four weeks. The patient had no covid prior vaccination. The patient had no known allergies. The day after the patient received the second dose of the vaccine, on 24Aug2021, the doctors identified concerns with the pregnancy (related to blood flow in the umbilical cord). These concerns ultimately to patient had delivered at 29 weeks and baby ultimately passing away on the same day. The events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care, hospitalization from 24Aug2021, life threatening illness (immediate risk of death from the event), and disability or permanent damage. The patient was tested for covid post vaccination on an unknown date which included nasal swab (unknown results). The outcome of the events was unknown.   The lot number for the vaccine BNT162B2 was not provided and will be requested during follow up.; Sender's Comments: Linked Report(s) : -PFIZER INC-202101210524 fetal case
c/o pain & swelling in lt deltoid region; started in PM of same day follwoing vax given 4NOV92; still c/o pain in upper arm & does not have complete use;
Fever; Chills; Headache; Sever Body aches; Change in menstrual  cycle up to and possible beyond 2 month of last dose; This is a spontaneous report from a contactable healthcare professional, the patient. A 39-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 13Mar2021 at the age of 39-years-old as a single dose for COVID-19 immunisation. Medical history included rheumatoid arthritis, atopic dermatitis, asthma, calculus of the kidney, migraines, cystic-bullous disease of lung, and multiple idiopathic pulmonary cysts. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received unspecified concomitant medication within two weeks of vaccination. The patient previously received ESTROGEN from an unknown date for an unknown indication and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6200) via an unspecified route of administration in the left arm on 20Feb2021 at the age of 39-years-old as a single dose for COVID-19 immunisation. On 12Apr2021, the patient experienced fever, chills, headache, sever body aches, changes in menstrual cycle up to, and possible beyond 2 months of last dose. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, chills, headache, sever body aches, change in menstrual cycle up, and possible beyond 2 months of last dose was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
COVID 19; COVID 19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 51-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 27Nov2021 as dos 3 (booster), single (Batch/Lot number: unknown) at the age of 50 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Hypothyroidism" (unspecified if ongoing); "HBP" (unspecified if ongoing). Concomitant medication(s) included: ATENOLOL; LIOTHYRONINE; HCTZ; MONTELUKAST; UNITHROID. Past drug history included: Met metformin, reaction(s): "known allergy: Metformin"; Red color in benadryl, reaction(s): "Known allergies: red color in Benadryl". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (28Sep2022) Positive, notes: I tested positive for Covid-19 again. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course information: Patient received other medications in two weeks Atenolol, Liothyronine of brand Zydus, HCTZ, Montelukast of brand, Unithroid of brand in two weeks. After isolating for 12 days and recovering, she went back to work. Two days later, 5 days since stopping Paxlovid, she developed a fever, cough and sore throat again. She tested positive for covid again same night. Now, she have had the same initial symptoms for 3 days, stuffy nose, cough, sore throat, and fever.  The information on the batch/lot number for [BNT162B2] has been requested and will be submitted if and when received.
arm became red/tender/swollen, infection site was swollen 6 inches across by 5 inches high, patient was icing and started antihistamine
This is a spontaneous report from a contactable consumer, the patient. A 22-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 08Apr2021 at 13:00 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. The patient medical history was reported as none. The patient did not have any allergies to food, medications, or other products. The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. On 08Apr2021 at 13:15, the patient experienced dizziness, nausea and extreme fatigue. The patient did not receive any treatment for the events. On an unknown date, the patient underwent nasal swab test and the result was inconclusive. The clinical outcome of the events dizziness, nausea and extreme fatigue were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
No adverse event; lot number O70H21A, that has an expiration date of 7 Apr 2022, which was received between 8 Apr 2022 and 15 Dec 2022; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (lot number O70H21A, that has an expiration date of 7 Apr 2022, which was received between 8 Apr 2022 and 15 Dec 2022) and NO ADVERSE EVENT (No adverse event) in a 64-year-old male patient who received mRNA-1273 (Spikevax) (batch no. O70H21A) for COVID-19 prophylaxis.     No Medical History information was reported.    In 2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. In 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (lot number O70H21A, that has an expiration date of 7 Apr 2022, which was received between 8 Apr 2022 and 15 Dec 2022). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (lot number O70H21A, that has an expiration date of 7 Apr 2022, which was received between 8 Apr 2022 and 15 Dec 2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (lot number O70H21A, that has an expiration date of 7 Apr 2022, which was received between 8 Apr 2022 and 15 Dec 2022).    Patient's age was reported as 64 Year 1 Month. No concomitant medications were reported. completion date was reported as 07-Jul-2022. The vaccine from the vial with lot number O70H21A was administered to the patient in between a period of 08-Apr-2022 to 15-Dec-2022. No treatment medications were reported.
Im still not feeling well/When will I feel better; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Im still not feeling well/When will I feel better) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MALAISE (Im still not feeling well/When will I feel better). At the time of the report, MALAISE (Im still not feeling well/When will I feel better) had not resolved.            No treatment information was provided. No concomitant medications were reported.
8 hours after the vaccination, patient felt cold/chills along with ascending body temperature.  Then, patient felt hot. Dizziness and fever persisted for almost 12 hours. Patient waking up in the morning felt lose of appetite due to nausea.
SIRVA after influenza vaccine. Pt with adhesive capsulitis. Outcome TBD - pt sent to physical therapy.
Dizziness of onset 8 days after administration of 2nd dose of vaccine, continues to be present
Patient called about an hour after the vaccine and advised she was itching and her eyes had started to swell and she had just taken 25mg of Benadryl.  She advised that she was not experiencing any other swelling such as throat.  Advised patient she can repeat Benadryl and if does not experience improvement or symptoms worsen to seek medical attention.
w/in 30 seconds, rt leg became erythematous & edematous; no resp distress; DPH given po, cold compress to leg; 15 mins p/vax dec erythema;
In the span of about 40 minutes following the shot, I had severe reactions. I initially felt really warm in my arm and my heart started to race for a bit. That subsided pretty quickly. Then I got really dizzy, lightheaded and warm and sweaty while waiting the 15 minutes. Then my vision started to blur and I felt tingly in both of my hands and both of my legs. According to others with me, I also went grey. I was given a cool cloth and fanned which helped with a lot of the issues. I also had my legs elevated and was given some slightly sugary food and drink to help the vaccine disperse better. Paramadics and amabulance arrived to assess me. I was improving by the time they arrived and was deemed stable, so I did not go to the hospital for this incident
I had numbness in fingers in left arm. I still exp it now it's not as bad. I'm scheduled to have a EEG later this month with the Neurologist.
1 red, swollen left arm after vaccination 2 days ago.  Ice to arm, Benadryl 125m/5cc 4cc per mouth three times a day as occasion requires.
pt recv vax 21ARP95 & lt deltoid was sore that noc & cont to be sore; tender when touched-hurts when arm lifted; no temp, or drainage;
Improperly stored Flulaval administered; This case was reported by a nurse via other manufacturer and described the occurrence of incorrect storage of drug in an unspecified number of patients who received Flu Seasonal TIV Quebec (Flulaval) for prophylaxis.   Co-suspect products included flu seasonal tiv quebec ?????????? (????) (Flulaval Pre-Filled Syringe Device) injection syringe for prophylaxis.   On an unknown date, the patient received Flulaval and Flulaval Pre-Filled Syringe Device. On an unknown date, unknown after receiving Flulaval and Flulaval Pre-Filled Syringe Device, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 28-Feb-2023 Reporter's Comments:  The reporter mentioned that separate patients administered either improperly stored, separate Flulaval separate Menactra or improperly stored and separate Trumenba on unknown date.  Improperly stored or separate Other Company Vaccine Detail Summary was located within following space. reporter was unable to further clarify these statements at current call time. No PQC reported. No further information provided. Additional Supportive Information: the patients received Flulaval vaccine, which was improperly stored, which led to incorrect storage of drug.
Pt received 0.5ml instead of 0.25ml Moderna 6m-11yr covid vaccine.
Patient's mother went to check on her son who was napping in his bedroom. The patient's mother found him unconscious/not breathing and the parents immediately called EMS. Pt presents as pale and unresponsive, however still warm to the touch.  EMS arrived and confirmed that the patient did not have a pulse and was not breathing. Patient was placed on a monitor which indicated Asystole. ACLS was performed per protocol for 30 minutes without any change in the patient's status. The patient was determined to be deceased at 22:31 on 10/28/22.
On 1/9/21 I slept fitfully, woke up in a cold sweat but had a normal temp of 38.4. I had a headache, body aches, and nausea also. This was approx 16 hours post dose. I took 600mg of ibuprofen and felt more able to do normal home activities but still tired with a sore arm. 4.5 hours post ibuprofen dose I again had muscle aches, headache, fatigue, and nausea. I also had chills and joint pain. I napped for an hour, took another 600mg ibuprofen, and then napped for another 2.5 hours. After that I felt better at 27 hours post dose but still achy and fatigued. These symptoms had mostly resolved by 31 hours post dose.
heart rate was flying; measured 113; usually resting rate is 60; sinus infection; This spontaneous case was reported by a consumer and describes the occurrence of TACHYCARDIA (heart rate was flying; measured 113; usually resting rate is 60) and SINUSITIS (sinus infection) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B21A) for COVID-19 vaccination.     No medical history information was reported.  Concomitant products included HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM (LOSARTAN HCTZ) from 2017 to an unknown date and CARVEDILOL from 2019 to an unknown date for Blood pressure high, ATORVASTATIN from 2017 to an unknown date for Cholesterol, FINASTERIDE from 2018 to an unknown date for Hair loss, VITAMIN C [ASCORBIC ACID], VITAMIN D NOS and ZINC for an unknown indication.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, the patient experienced TACHYCARDIA (heart rate was flying; measured 113; usually resting rate is 60) and SINUSITIS (sinus infection). The patient was treated with AZITHROMYCIN (Z-PAK) for Sinus infection, at an unspecified dose and frequency. On 24-Mar-2021, TACHYCARDIA (heart rate was flying; measured 113; usually resting rate is 60) had resolved. On 07-Apr-2021, SINUSITIS (sinus infection) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Heart rate: 113 (High) 113.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 12-May-2021: (Follow up  received on 12 May 2021) patient demographics, vaccination facility details added. Concomitant medication, events updated
anxiety; shortness of breath; woke up with lump under her left arm; woke up with lump under her left arm It's like a lymph node; This spontaneous case was reported by a consumer and describes the occurrence of ANXIETY (anxiety), DYSPNOEA (shortness of breath), MASS (woke up with lump under her left arm) and LYMPHADENOPATHY (woke up with lump under her left arm It's like a lymph node) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  The patient's past medical history included Cancer surgery (Patient had left breast cancer surgery done in 2010; only one of the duct. It was removed,treated, and now fine.). Concurrent medical conditions included Depression (got really bad depression during lockdown). Concomitant products included LOSARTAN for Hypertension, Syntroid, FOLIC ACID, VITAMIN D3, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) and CYANOCOBALAMIN (VITAMIN B12 [CYANOCOBALAMIN]) for an unknown indication.   On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 17-Apr-2021, the patient experienced ANXIETY (anxiety), DYSPNOEA (shortness of breath), MASS (woke up with lump under her left arm) and LYMPHADENOPATHY (woke up with lump under her left arm It's like a lymph node). At the time of the report, ANXIETY (anxiety), DYSPNOEA (shortness of breath), MASS (woke up with lump under her left arm) and LYMPHADENOPATHY (woke up with lump under her left arm It's like a lymph node) outcome was unknown.            Patient reported that she had to go the ER. Her son is a pharmacist who took her. They did CT scans, draw blood every 2 hours, did a lot of tests. They didn't see anything. On 21-Apr-2021, she went to see oncologist for a regular appointment. He noticed the lump. He wanted to see her in 5 weeks.
Patient received Moderna COVID vaccine on 2/8/21, 3/8/21, 9/9/21 and Moderna bivalent COVID vaccine on 10/12/22. On 12/1/22, patient admitted to our inpatient facility (med/surg unit) for acute hypoxic respiratory failure due to COVID-19 pneumonia. As of today 12/7/22, patient is still admitted in the med/surg unit.
The day after my vaccine I woke up and felt fine I went out to do my normal daily activities but I started to feel dehydrated and light headed. I went home hours later and I started to really feel bad, my head was hurting and my throat started closing and because I had asthma I tried to use my inhaler but that didn't work. Around 4:30pm on 3/13 I went to the emergency room and they gave me a breathing treatment upon arrival. The doctor said it wasn't much they could do and cant exactly say that it was a allergic reaction but I felt like it was.
Severe headache onset one minute after vaccine administered-reported to nurse. Lasted 8 hours, by 1 week daily but less severe. Nausea and dizziness began 15 minutes after dosage and has lasted seven days so far. Passed out and needed help standing twice during week. Low blood pressures 88/62, HR 42. Symptoms continue presently.
Pain during injection and not being able to move arm a couple hours after receiving injection. Patient said she did not experience any injection site reaction (redness, swelling, warmness).
Day one hard lump appeared 3-4  inches BELOW injection site. Day 3 the lump disappeared . Day 9 a maculopapular rash developed over former site of the lump and persists. The  rash is red and very itchy and measures about 2.5 wide X 3-4 inches long.  Treating with topical steroids.  Observing for spread.
A non-serious spontaneous report of administration to 76 year old was received from a registered nurse concerning a 76-year-old female. Neither relevant medical history nor concomitant medications have been reported for this patient. On 22-Jan-2010, the patient received H1N1, Intranasal for an unknown indication. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event is considered resolved.
9/10/21 PMH of perforated diverticulitis s/p Hartmann's at hospital c/b right ureteral injury s/p ureteral reimplantation, LOA, and repair of serosal defect in TI c/o abscess, fistula
He had a fever, runny nose, and coughing. His fever got up to 102.7-degrees. They lasted about a week. I gave him TYLENOL.
Fever 1 day after. Torticollis -stiff neck, only turns to left side, seeing chiropractor.
Severe Dizziness/Vertigo.  Almost fell down upon rising from bed to use restroom during middle of night.  This began roughly 14-15 hrs after vaccine administered.  Noticeably dizzy, especially when bending over and re-rising to standing position.  This persisted for 3 full days beyond date of vaccination.  By 10/27/2015, the dizziness/vertigo subsided fully.  Have had no symptoms after 10/27/2015.  Very distressing though for the 3 days I did feel the dizziness/vertigo.  Have never experienced this before.
After about 15 minutes I started to feel my scalp itching and tingling. The itching started to spread. Took Benadryl. Itching continued to be rather intense all night. In the morning I woke to hear my heart pounding and pulsing in my ears and head - what I am told are heart palpitations. The itching subsided after two days. Flu like symptoms started the next night after the shot and subsided after a day. Extreme fatigue began immediately and continues today. Heart palpitations continued for weeks. I sought out my doctors office after a week. During this time I also experienced alarming chest pains and pain while breathing. This confused gor about 3-4 weeks. My doctors office seemed to not know to report this or seek advice so I lingered while tests were being run. I normally had a low heart per my Watch and during this time my heart rate was double my normal resting rate. The chest pains, breathing pains and heart palpitations have improved, but the extreme fatigue continues to impact my ability to keep my normal routine and I?m having to reduce my work hours and take days off just to rest.
This Covid shot has me so sick. I?m having the shortest of breath, bad back pain, joint pain and body aches. Chills, fever of 101.1, I felt faint today, sharp lower abdomen pain, sharp pain going down my arms and migraine headaches
started itching everywhere legs, arm, back.; a little red; her arm hurt a little; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (started itching everywhere legs, arm, back.), ERYTHEMA (a little red) and VACCINATION SITE PAIN (her arm hurt a little) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     Concomitant products included DICLOFENAC for an unknown indication.    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, the patient experienced VACCINATION SITE PAIN (her arm hurt a little). On an unknown date, the patient experienced PRURITUS (started itching everywhere legs, arm, back.) and ERYTHEMA (a little red). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PRURITUS (started itching everywhere legs, arm, back.), ERYTHEMA (a little red) and VACCINATION SITE PAIN (her arm hurt a little) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medication include Tylenol.